Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Other Accumulated Expenses (2016 - 2017)

Amicus Therapeutics filings provide 7 years of Other Accumulated Expenses readings, the most recent being $5.4 million for Q4 2017.

  • On a quarterly basis, Other Accumulated Expenses rose 136.03% to $5.4 million in Q4 2017 year-over-year; TTM through Dec 2017 was $5.4 million, a 136.03% increase, with the full-year FY2017 number at $5.4 million, up 136.03% from a year prior.
  • Other Accumulated Expenses hit $5.4 million in Q4 2017 for Amicus Therapeutics, up from $2.3 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $5.4 million in Q4 2017 to a low of $275000.0 in Q4 2013.
  • Median Other Accumulated Expenses over the past 5 years was $728000.0 (2014), compared with a mean of $1.7 million.
  • Biggest five-year swings in Other Accumulated Expenses: surged 164.73% in 2014 and later soared 34.79% in 2016.
  • Amicus Therapeutics' Other Accumulated Expenses stood at $275000.0 in 2013, then soared by 164.73% to $728000.0 in 2014, then skyrocketed by 133.38% to $1.7 million in 2015, then surged by 34.79% to $2.3 million in 2016, then soared by 136.03% to $5.4 million in 2017.
  • The last three reported values for Other Accumulated Expenses were $5.4 million (Q4 2017), $2.3 million (Q4 2016), and $607000.0 (Q3 2016) per Business Quant data.